According to numerous investigations, STAT3 activity is also a survival signal that guards against lipotoxicity, whereas blocking hepatic STAT3 activation with other drugs reduces NAFLD-induced liver fibrosis [82]. This evidence concerns the gene STAT3 and Hepatic fibrosis.